CELL AND GENE THERAPY INSIGHTS

Cell therapy manufacturing and bioprocessing

May 2025
Cell therapy manufacturing and bioprocessing

Innovator Insight

Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

David Shaw, Fred Parietti, Carl Dargitz
1 May
Read
Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Kasey Kime, Xiao Peng
20 March
Read

EBook

Next-gen immunotherapy: a guide for CGT developers

Next-gen immunotherapy: a guide for CGT developers

Alex Sargent
9 May
Read

Interview

Exploring strategies for scaling up allogeneic natural killer cell therapy

Exploring strategies for scaling up allogeneic natural killer cell therapy

Will Rosellini
2 May
Read
The path to PAT: the role of process analytical technologies in advancing CAR-T therapy production

The path to PAT: the role of process analytical technologies in advancing CAR-T therapy production

Sarah Rajani
1 May
Read
Digitalization and data analytics: shaping the future of cell bioprocessing

Digitalization and data analytics: shaping the future of cell bioprocessing

Mohamed Noor
1 May
Read
Driving innovation to advance allogeneic cell therapies through manufacturing platform development

Driving innovation to advance allogeneic cell therapies through manufacturing platform development

Jason Dowd
18 March
Read

Webinars

Fit-for-purpose analytical development for an emerging cell therapy landscape

Fit-for-purpose analytical development for an emerging cell therapy landscape

J Wei, D Marshall, F Durst
3 April
Watch
Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Nik Ekman
1 May
Watch
Navigating the transition from research to clinical-scale cell therapy manufacture

Navigating the transition from research to clinical-scale cell therapy manufacture

S Feldman, J Fruehauf, M Ann Santos
22 May
in 7
Days
Register
Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Srinath Kashi Ranganath
5 June
in 21
Days
Register
Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Alex Lei
19 June
in 35
Days
Register